Literature DB >> 4439865

Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections.

K Masek, F Perlík, J Klíma, R Kahlich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4439865     DOI: 10.1007/BF00560353

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  14 in total

1.  FATTY ACID AMIDES OF ETHANOLAMINE IN MAMMALIAN TISSUES.

Authors:  N R BACHUR; K MASEK; K L MELMON; S UDENFRIEND
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  Acellular bacterial antigen complex (Hoffmann) in the treatment of children with recurrent respiratory infections and infectious asthma.

Authors:  J E GUNDY
Journal:  J Pediatr       Date:  1957-11       Impact factor: 4.406

3.  Non-specific resistance induced by palmitoylethanolamide.

Authors:  H Rasková; K Masek; O Linèt
Journal:  Toxicon       Date:  1972-08       Impact factor: 3.033

4.  Common cold and vitamin C.

Authors:  C W Wilson; H S Loh
Journal:  Lancet       Date:  1973-03-24       Impact factor: 79.321

5.  Inhibition of respiratory virus infection by locally applied interferon.

Authors:  T C Merigan; S E Reed; T S Hall; D A Tyrrell
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

6.  Structural and functional changes in liver mitochondria of mice fed palmitoylethanolamide (PEA).

Authors:  H Obermajerová; K Masek; J Seifert; E Buchar; I Havlík
Journal:  Biochem Pharmacol       Date:  1973-10-15       Impact factor: 5.858

7.  Relationship of reticuloendothelial functional activity to endotoxin lethality.

Authors:  C G Crafton; N R Di LUZIO
Journal:  Am J Physiol       Date:  1969-09

8.  Effects of glyceryl trioleate on the reticuloendothelial system and survival after experimental shock.

Authors:  B M Altura; S G Hershey
Journal:  J Pharmacol Exp Ther       Date:  1970-12       Impact factor: 4.030

9.  Resistance-enhancing properties against Salmonella typhimurium infection and pyrogenic activity of simple lipids.

Authors:  J P Ransom; D Willner
Journal:  J Reticuloendothel Soc       Date:  1965-09

10.  Vitamin C and the common cold: a double-blind trial.

Authors:  T W Anderson; D B Reid; G H Beaton
Journal:  Can Med Assoc J       Date:  1972-09-23       Impact factor: 8.262

View more
  12 in total

1.  Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2014-05-27       Impact factor: 4.473

2.  Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages.

Authors:  Chenggang Zhu; Carlos Solorzano; Saurabh Sahar; Natalia Realini; Ernest Fung; Paolo Sassone-Corsi; Daniele Piomelli
Journal:  Mol Pharmacol       Date:  2011-01-13       Impact factor: 4.436

3.  Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.

Authors:  Roberto Russo; Jesse LoVerme; Giovanna La Rana; Giuseppe D'Agostino; Oscar Sasso; Antonio Calignano; Daniele Piomelli
Journal:  Eur J Pharmacol       Date:  2007-03-19       Impact factor: 4.432

4.  Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.

Authors:  Giuseppe D'Agostino; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Rosaria Meli; Antonio Calignano
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

Review 5.  Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives.

Authors:  Rutger Kriek
Journal:  Inflammopharmacology       Date:  2014-03-20       Impact factor: 4.473

6.  Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.

Authors:  Sandra Redlich; Sandra Ribes; Sandra Schütze; Roland Nau
Journal:  J Neuroinflammation       Date:  2014-06-14       Impact factor: 8.322

7.  Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical.

Authors:  Jan M Keppel Hesselink
Journal:  J Pain Res       Date:  2013-08-08       Impact factor: 3.133

Review 8.  Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold.

Authors:  J M Keppel Hesselink; Tineke de Boer; Renger F Witkamp
Journal:  Int J Inflam       Date:  2013-08-27

Review 9.  Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.

Authors:  Jan M Keppel Hesselink; Ciro Costagliola; Josiane Fakhry; David J Kopsky
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

10.  Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.

Authors:  Nicola Antonucci; Alessandra Cirillo; Dario Siniscalco
Journal:  Case Rep Psychiatry       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.